CN103923095A — 一种去甲基斑蝥素酸钙
Assigned to Zunyi Medical University · Expires 2014-07-16 · 12y expired
What this patent protects
本发明公开了一种去甲基斑蝥素酸钙,其结构式如下。其制备方法是加热设定体积的去离子水至70-80℃,加入设定量的去甲斑蝥素,使其终浓度为12.5mmol/L。加入设定量氢氧化钙,使去甲斑蝥素与氢氧化钙的摩尔比为1:1。加热磁力搅拌反应30-60min,10000g离心30min,弃沉淀留上清。上清60℃减压干燥后,得无色无规则晶体,即得。本发明具有较高抗癌活性,工艺简单,易于操作,安全性好,成品性能稳定,纯度高的特点。
USPTO Abstract
本发明公开了一种去甲基斑蝥素酸钙,其结构式如下。其制备方法是加热设定体积的去离子水至70-80℃,加入设定量的去甲斑蝥素,使其终浓度为12.5mmol/L。加入设定量氢氧化钙,使去甲斑蝥素与氢氧化钙的摩尔比为1:1。加热磁力搅拌反应30-60min,10000g离心30min,弃沉淀留上清。上清60℃减压干燥后,得无色无规则晶体,即得。本发明具有较高抗癌活性,工艺简单,易于操作,安全性好,成品性能稳定,纯度高的特点。
Drugs covered by this patent
- Ycanth (CANTHARIDIN) · Verrica Pharms
Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.
Track this patent
Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.